Philippe Guillaume

10.8k total citations · 1 hit paper
142 papers, 7.9k citations indexed

About

Philippe Guillaume is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Philippe Guillaume has authored 142 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Immunology, 44 papers in Molecular Biology and 40 papers in Oncology. Recurrent topics in Philippe Guillaume's work include Immunotherapy and Immune Responses (86 papers), T-cell and B-cell Immunology (73 papers) and Immune Cell Function and Interaction (61 papers). Philippe Guillaume is often cited by papers focused on Immunotherapy and Immune Responses (86 papers), T-cell and B-cell Immunology (73 papers) and Immune Cell Function and Interaction (61 papers). Philippe Guillaume collaborates with scholars based in Switzerland, United States and Germany. Philippe Guillaume's co-authors include Immanuel F. Luescher, Pedro Romero, Daniel E. Speiser, Jean‐Charles Cerottini, Hassane M. Zarour, Danila Valmori, Julien Fourcade, John M. Kirkwood, Zhaojun Sun and Cindy Sander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Philippe Guillaume

138 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

2010 1.0k citations Julien Fourcade, Zhaojun Sun et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Philippe Guillaume

Since Specialization

Citations

This map shows the geographic impact of Philippe Guillaume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Guillaume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Guillaume more than expected).

Fields of papers citing papers by Philippe Guillaume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Guillaume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Guillaume. The network helps show where Philippe Guillaume may publish in the future.

Co-authorship network of co-authors of Philippe Guillaume

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Guillaume. A scholar is included among the top collaborators of Philippe Guillaume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Guillaume. Philippe Guillaume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of the French version of the Body Awareness Questionnaire: toward a way to assess alexisomia 2024 ·Frontiers in Psychology ·Arnaud Carré, Rébecca Shankland, Philippe Guillaume, Jeanne Duclos, (unknown), Sonia Pellissier, Valentin Flaudias	0
2	Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model 2024 ·International Journal of Molecular Sciences ·Philippe Guillaume, Tristan Rupp, Guillaume Froget, (unknown)	2
3	Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients 2020 ·Journal for ImmunoTherapy of Cancer ·(unknown), Philippe Guillaume, Amélie Cachot, Margaux Saillard, Daniel E. Speiser, George Coukos, Alexandre Harari, Pedro Romero, Julien Schmidt, Camilla Jandus	4
4	Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands 2019 ·Molecular & Cellular Proteomics ·(unknown), Philippe Guillaume, Julien Racle, Justine Michaux, HuiSong Pak, Markus Müller, George Coukos, Michal Bassani‐Sternberg, David Gfeller	42
5	Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes 2019 ·Nature Biotechnology ·Julien Racle, Justine Michaux, (unknown), Marion Arnaud, Sara Bobisse, Chloé Chong, Philippe Guillaume, George Coukos, Alexandre Harari, Camilla Jandus, Michal Bassani‐Sternberg, David Gfeller	200
6	The C-terminal extension landscape of naturally presented HLA-I ligands 2018 ·Proceedings of the National Academy of Sciences ·Philippe Guillaume, S. Picaud, Petra Baumgaertner, Nicole Montandon, Julien Schmidt, Daniel E. Speiser, George Coukos, Michal Bassani‐Sternberg, P. Filippakopoulos, David Gfeller	35
7	Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity 2017 ·PLoS Computational Biology ·Michal Bassani‐Sternberg, Chloé Chong, Philippe Guillaume, (unknown), HuiSong Pak, Philippe O. Gannon, Lana E. Kandalaft, George Coukos, David Gfeller	177
8	Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial 2015 ·Clinical Cancer Research ·Amandine Legat, Hélène Maby–El Hajjami, Petra Baumgaertner, Laurène Cagnon, Samia Abed Maillard, Christine Geldhof, Emanuela M. Iancu, Luc Lebon, Philippe Guillaume, Danijel Dojcinovic, Olivier Michielin, Emanuela Romano, Grégoire Berthod, Donata Rimoldi, Frédéric Triebel, Immanuel F. Luescher, Nathalie Rufer, Daniel E. Speiser	76
9	Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR–Ligand Off-Rates Measurements on Living Cells 2015 ·Cancer Research ·Michaël Hebeisen, Julien Schmidt, Philippe Guillaume, Petra Baumgaertner, Daniel E. Speiser, Immanuel F. Luescher, Nathalie Rufer	38
10	PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines 2013 ·Cancer Research ·Julien Fourcade, Zhaojun Sun, Ornella Pagliano, (unknown), Cindy Sander, Bratislav Janjic, Ahmad A. Tarhini, Hussein A. Tawbi, John M. Kirkwood, Stergios J. Moschos, Hong Wang, Philippe Guillaume, Immanuel F. Luescher, Arthur Μ. Krieg, Ana C. Anderson, Vijay K. Kuchroo, Hassane M. Zarour	175
11	CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1 2011 ·Cancer Research ·Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Daniel Olive, Vijay K. Kuchroo, Hassane M. Zarour	291
12	Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients breakdown → 2010 ·The Journal of Experimental Medicine ·Julien Fourcade, Zhaojun Sun, Mourad Benallaoua, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Vijay K. Kuchroo, Hassane M. Zarour	1032
13	HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine 2008 ·Clinical Cancer Research ·Gilles Bioley, Philippe Guillaume, Immanuel F. Luescher, (unknown), Bo Dupont, Nina Bhardwaj, Gregory Mears, Lloyd J. Old, Danila Valmori, Maha Ayyoub	15
14	Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity 2006 ·The Journal of Immunology ·Georgi S. Angelov, Philippe Guillaume, Marek Cebecauer, Giovanna Bosshard, Danijel Dojcinovic, Petra Baumgaertner, Immanuel F. Luescher	20
15	TCR-α CDR3 Loop Audition Regulates Positive Selection 2006 ·The Journal of Immunology ·Cristina Ferreira, Anna L. Furmanski, Maggie Millrain, I Bartók, Philippe Guillaume, Rosemary K. Lees, Elizabeth Simpson, H. Robson MacDonald, Julian Dyson	8
16	Ex Vivo Characterization of Allo-MHC-Restricted T Cells Specific for a Single MHC-Peptide Complex 2006 ·The Journal of Immunology ·Mikäel J. Pittet, Asma Gati, (unknown), Gilles Bioley, Philippe Guillaume, Magda De Smedt, Jean Plum, Daniel E. Speiser, Jean‐Charles Cerottini, Pierre‐Yves Dietrich, Pedro Romero, Alfred Zippelius	20
17	Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting 2002 ·Journal of Clinical Investigation ·Valérie Dutoit, Robert N. Taub, Kyriakos P. Papadopoulos, Susan Talbot, (unknown), (unknown), Sacha Gnjatic, Paul E. Harris, Brygida Bisikirska, Philippe Guillaume, Jean‐Charles Cerottini, Charles S. Hesdorffer, Lloyd J. Old, Danila Valmori	9
18	Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL 2002 ·The Journal of Immunology ·Verena Rubio‐Godoy, Valérie Dutoit, Yingdong Zhao, Richard Simon, Philippe Guillaume, Richard A. Houghten, Pedro Romero, Jean‐Charles Cerottini, Clemencia Pinilla, Danila Valmori	51
19	The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector αβ T Cells 2001 ·The Journal of Immunology ·Daniel E. Speiser, Marco Colonna, Maha Ayyoub, Marina Cella, Mikäel J. Pittet, Pascal Batard, Danila Valmori, Philippe Guillaume, Danielle Líénard, Jean‐Charles Cerottini, Pedro Romero	74
20	Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma 2000 ·The Journal of Immunology ·Donata Rimoldi, Verena Rubio‐Godoy, Valérie Dutoit, Danielle Líénard, Suzanne Salvi, Philippe Guillaume, Daniel E. Speiser, Elisabeth Stockert, Giulio C. Spagnoli, Catherine Servis, Jean‐Charles Cerottini, Ferdy J. Lejeune, Pedro Romero, Danila Valmori	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact